The Supreme Court has temporarily halted a lower court ban on mailing mifepristone, allowing continued access to the medication while legal arguments proceed.This case challenges the authority of the FDA and raises the possibility that the Comstock Act could be used to restrict reproductive services nationwide.The outcome may create significant disparities in access by effectively ending a common method used for the majority of abortions in the US.